Børge Diderichsen was born in 1952. He has a master’s degree in biochemistry (1976) and a PhD in microbiology (1980) from the University of Copenhagen.
In 1981, he joined Novo Industry as one of a small team of researchers who were to develop the use of genetically modified organisms for the production of insulin and industrial enzymes.
Børge Diderichsen was appointed director of “Gene-Technology” in 1991 and Vice President of “Strategic Research Management” in 1993, a new unit coordinating research and patent strategies, the first of its kind in Europe. In 1996, he was appointed Vice President of “Corporate Research Affairs” to formulate Novo Nordisk’s views on research policy, to interact with ministries, the European Commission, Chinese Academy of Sciences and other organisations in China, to build and maintain partnerships with universities, ministries, organisations etc., and to manage Novo Nordisk R&D Science, Talent, Attraction and Recruitment Program for PhD students and PostDocs. In 2012, he was appointed Vice President of “R&D Outreach”, with focus on building research based relations with universities, research institutes and other public institutions in China, Argentina and other emerging markets.